ReShape Lifesciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Oct 23 | SellUS$295 | Thomas Stankovich | Individual | 357 | US$1.43 | |
11 Oct 23 | SellUS$92 | Thomas Stankovich | Individual | 78 | US$1.42 | |
06 Jul 23 | SellUS$156 | Thomas Stankovich | Individual | 106 | US$1.47 | |
30 Jun 23 | BuyUS$26,907 | Thomas Stankovich | Individual | 17,702 | US$1.52 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 49,569 | 0.211% |
Institutions | 225,928 | 0.963% |
Individual Insiders | 2,618,975 | 11.2% |
General Public | 20,562,618 | 87.7% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 697.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,461,000 | US$471.5k | 0% | no data | |||
133,853 | US$25.6k | 0% | no data | |||
49,874 | US$9.6k | 0% | no data | |||
49,569 | US$9.5k | 190% | no data | |||
34,060 | US$6.5k | 0% | no data | |||
29,785 | US$5.7k | 40.6% | no data | |||
23,282 | US$4.5k | 0% | no data | |||
23,036 | US$4.4k | 0% | no data | |||
22,926 | US$4.4k | 0% | no data | |||
18,348 | US$3.5k | 0% | no data | |||
13,015 | US$2.5k | 0% | no data | |||
12,820 | US$2.5k | -83% | no data | |||
12,296 | US$2.4k | 0% | no data | |||
9,038 | US$1.7k | 0% | no data | |||
840 | US$160.9 | 0% | no data | |||
400 | US$76.9 | -20% | no data | |||
183 | US$35.1 | 81.2% | no data | |||
135 | US$26.1 | 0% | no data | |||
5 | US$0.9 | 0% | no data | |||
3 | US$0.4 | 0% | no data | |||
2 | US$0.4 | 0% | no data | |||
1 | US$0 | 0% | no data | |||
1 | US$0 | 0% | no data |